Libby Hamson
Global Pricing and Market Access Director, GSK
Libby Hamson is listed as Global Pricing and Market Access Director, GSK. Libby spoke at ISPOR Europe 2026 in November 2026 (speaker, “Whole Health at Risk: Does EU Joint Clinical Assessment Conflict with Europe’s Antimicrobial Resistance Ambitions?”). Speaks mainly at Government Administration events.
Compiled from published conference agendas; not yet confirmed by Libby. Is this you? Claim this profile.
- Sector: Government Administration
Sessions at 1 conference
ISPOR Europe 2026 8 November 2026 – 11 November 2026
- Whole Health at Risk: Does EU Joint Clinical Assessment Conflict with Europe’s Antimicrobial Resistance Ambitions? Speaker · 9 November 2026
Spoke alongside
People who have shared a session with Libby at events on B2DB.
- Anja E Schiel Norwegian Medicines Agency 1 shared session
- Matthias Hofer Principal Economist · Office of Health Economics 1 shared session
- Patrick K Hopkinson Independent Consultant 1 shared session
Others from GSK
- Sam M. Rowe Investigator 2 sessions
- Shobie Ramakrishnan Chief Digital and Technology Officer 2 sessions
- Anthony Rowe VP Onyx Research 1 session
- David Egan Assistant General Counsel, Global Digital and Privacy 1 session
- Ian Wall Head Molecular Design 1 session
- Jeffrey T. Hamilton Head, Payer Partnership & Policy - Global Pricing and Market Access 1 session
- Juergen Loskutov Scientific Leader, Bio Bank 1 session
- Luke Bellamy Director MSAT Systems & Informatics - Global Manufacturing Science & Technology 1 session
- Tim Ashlin Team Leader and Principal Investigator 1 session
- Yasmin Zobedey NHS Strategy, Portfolio and Partnerships Senior Manager 1 session